Decision Support for the Design of Clinical Trials: Dose De-escalation in HPV plus Oropharyngeal Cancer

被引：0
作者：
Smith, W. P. [1 ]
Gennari, J. [2 ]
Parvathaneni, U. [1 ]
Liao, J. J. [1 ]
Phillips, M. H. [1 ]
机构：
[1] Univ Washington, Dept Radiat Oncol, Seattle, WA 98195 USA
[2] Univ Washington, Dept Biomed Informat & Med Educ, Seattle, WA 98195 USA
来源：
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2017年 / 99卷 / 02期
关键词：
D O I：
10.1016/j.ijrobp.2017.06.1596
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
2986
引用
收藏
页码：E415 / E415
页数：1
相关论文
共 50 条
  • [11] Maximum Tolerated Dose Estimation with Dose De-Escalation Design in a Phase I Clinical Trials
    Jang, Eunah
    Kim, Dongjae
    KOREAN JOURNAL OF APPLIED STATISTICS, 2014, 27 (07) : 1115 - 1123
  • [12] HPV-related oropharyngeal carcinoma de-escalation protocols
    Mesia, Ricard
    Taberna, Miren
    LANCET ONCOLOGY, 2017, 18 (06) : 704 - 705
  • [13] Estimated benefit of proton therapy and dose de-escalation in HPV p16-positive oropharyngeal cancer
    Brodin, P.
    Kabarriti, R.
    Gondi, V.
    Pankuch, M.
    Garg, M.
    Tome, W.
    RADIOTHERAPY AND ONCOLOGY, 2019, 133 : S644 - S645
  • [14] Practice patterns and outcomes following radiation dose de-escalation for oropharyngeal cancer
    White, Richard
    Abel, Stephen
    Hasan, Shaakir
    Verma, Vivek
    Greenberg, Larisa
    Colonias, Athanasios
    Wegner, Rodney E.
    LARYNGOSCOPE, 2020, 130 (04) : E171 - E176
  • [15] Involved Site Radiotherapy in HPV Positive Oropharyngeal Cancer: Patterns of Failure Analysis Across Prospective De-Escalation Trials
    Iftekaruddin, Z.
    Huang, D.
    Hara, J.
    Rosenberg, A. J.
    Arshad, M.
    Pearson, A.
    Katipally, R. R.
    Gooi, Z.
    Blair, E. A.
    Agrawal, N.
    Vokes, E. E.
    Haraf, D. J.
    Juloori, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2023, 117 (02): : S68 - S68
  • [16] Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives
    Mirghani, H.
    Amen, F.
    Blanchard, P.
    Moreau, F.
    Guigay, J.
    Hartl, D. M.
    St Guily, J. Lacau
    INTERNATIONAL JOURNAL OF CANCER, 2015, 136 (07) : 1494 - 1503
  • [17] Patient preferences for oropharyngeal cancer treatment de-escalation
    Brotherston, Drew C.
    Poon, Ian
    Le, Tuyen
    Leung, Martin
    Kiss, Alex
    Ringash, Jolie
    Balogh, Judith
    Lee, Justin
    Wright, James R.
    HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK, 2013, 35 (02): : 151 - 159
  • [18] Dosimetric Results for Organs at Risk (OAR) from Radiotherapy Dose De-Escalation to the Subclinical Region in HPV-Mediated Oropharyngeal Cancer (HPV plus OPC): A Retrospective Analysis
    Miller, D. G.
    Youssef, I.
    Kallini, D.
    Yu, Y.
    Zakeri, K.
    Chen, L.
    Shamseddine, A.
    Gelblum, D.
    McBride, S.
    Riaz, N.
    Aliotta, E.
    Aristophanous, M.
    Lee, N. Y.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2024, 120 (02): : E774 - E775
  • [19] De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?
    Golusinski, Pawel
    Corry, June
    Vander Poorten, Vincent
    Simo, Ricard
    Sjogren, Elisabeth
    Makitie, Antti
    Kowalski, Luis Paulo
    Langendijk, Johannes
    Braakhuis, Boudewijn J. M.
    Takes, Robert P.
    Coca-Pelaz, Andres
    Rodrigo, Juan P.
    Willems, Stefan M.
    Forastiere, Arlene A.
    De Bree, Remco
    Saba, Nabil F.
    Teng, Yong
    Sanabria, Alvaro
    Di Maio, Pasquale
    Szewczyk, Mateusz
    Ferlito, Alfio
    ORAL ONCOLOGY, 2021, 123
  • [20] Treatment de-escalation for HPV-driven oropharyngeal cancer: Where do we stand?
    Mirghani, Haitham
    Blanchard, Pierre
    CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY, 2018, 8 : 4 - 11
12345